ConductScience.org, home

Paper41279375

Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape.

Williams JB and 10 others. bioRxiv, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape. Papers, record 41279375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41279375

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape.
PubMed
Journal
bioRxiv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI127654NIAID NIH HHSUnited StatesR01AI127654PubMed and NIHNIH RePORTER
R01 AR065807NIAMS NIH HHSUnited StatesR01AR065807PubMed and NIHNIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134179824Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.Nat Cancer2021https://conductscience.org/library/papers/34179824PubMed
231810882Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.Immunity2019https://conductscience.org/library/papers/31810882PubMed
338455971Tissue-resident memory T cell signatures from single-cell analysis associated with better melanoma prognosis.iScience2024https://conductscience.org/library/papers/38455971PubMed
426688350Tissue-resident memory T cells: local specialists in immune defence.Nat Rev Immunol2016https://conductscience.org/library/papers/26688350PubMed
539142275Resident memory T cells and cancer.Immunity2024https://conductscience.org/library/papers/39142275PubMed
637607911Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy.Nat Commun2023https://conductscience.org/library/papers/37607911PubMed
725725111CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.J Immunol2015https://conductscience.org/library/papers/25725111PubMed
830598548Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin.Nature2019https://conductscience.org/library/papers/30598548PubMed
937545498Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy.Front Immunol2023https://conductscience.org/library/papers/37545498PubMed
1038969523TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response.J Immunother Cancer2024https://conductscience.org/library/papers/38969523PubMed
1124162776The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.Nat Immunol2013https://conductscience.org/library/papers/24162776PubMed
1228552347Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation.Cell2017https://conductscience.org/library/papers/28552347PubMed
1328486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
1428628092Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.Nat Immunol2017https://conductscience.org/library/papers/28628092PubMed
1529769722Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.Nature2018https://conductscience.org/library/papers/29769722PubMed
1628018343Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.Front Immunol2016https://conductscience.org/library/papers/28018343PubMed
1728219080Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.Nature2017https://conductscience.org/library/papers/28219080PubMed
1825787765Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.Sci Transl Med2015https://conductscience.org/library/papers/25787765PubMed
1937392736Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts.Immunity2023https://conductscience.org/library/papers/37392736PubMed
2030026331Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis.Cancer Res2018https://conductscience.org/library/papers/30026331PubMed

See all 54 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41869343Risk factors and immune landscape of early local tumor progression after microwave ablation for lung cancer: a retrospective nested case-control study.Front Immunol2026https://conductscience.org/library/papers/41869343

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41279375

GET https://conductscience.org/api/papers/v1/41279375/references?page=2